drugset / Trial / NCT00508287
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of single doses of BMS-686117
Timeline
- Start
- 2007-08
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-686117 | Protein / enzyme biologic | 1 mg | Subcutaneous |
| Comparator | Exenatide | Peptide | 5 ug | Subcutaneous |